COVID-19 – Call to Action
The global crisis caused by the SARS-Cov2 outbreak requires rapidly applicable therapeutics. Available approved drug substances represent one of the more realistic paths to clinical use within weeks or months. Delta4 is aiming to use its digital drug development platform to screen repurposing opportunities for COVID-19. Currently our computational biology staff is preparing to curate […]